Abbvie Inc
NYSE: ABBV
$177.60
+$0.65 (+0.4%)
Real Time Data Delayed 15 Min.
ABBV Articles
The Jefferies Healthcare Conference wrapped up in New York City last week, and the mood was reported as generally positive, with investors feeling much better than a few months ago.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday morning include Abbvie, Amazon.com, Cliffs Natural Resources, Corning, Dynegy, Joy Global and Stanley Black & Decker.
Published:
Last Updated:
The May 31 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
Moving some capital to lower volatility stocks makes sense as we head into summer. These four Jefferies Franchise Picks look like good additions now.
Published:
Last Updated:
The ASCO annual meeting is absolutely making waves in the pharmaceutical industry. As a result, analysts are giving their two cents on companies making presentations at the conference.
Published:
Last Updated:
Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology (ASCO) annual meeting, and it has issued a report on what it is looking for.
Published:
Last Updated:
Despite the ongoing political candidate chirping, all of these quality big pharmaceutical stocks have been around, and they will continue to stay around.
Published:
Last Updated:
The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society of Clinical Oncology (ASCO) is set to run from June 3 to June 7 in Chicago.
Published:
Last Updated:
The short interest data have been released for the April 29 settlement date, and for most of the selected pharmaceutical stocks short interest decreased.
Published:
Last Updated:
A pharmaceutical company could face a threat to one of its products for a number of reasons, ranging from an improved formulation to a patent expiry and the opening of the floodgates for generic...
Published:
Last Updated:
AbbVie reported its first-quarter financial results and guidance before the markets opened on Thursday.
Published:
Last Updated:
The April 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
Attaining a certain drug can mean the difference between life and death for millions of Americans. These essential products also help generate billions for drug manufacturers. Pharmaceutical...
Published:
Last Updated:
These four Jefferies Franchise Picks are rated Buy and pay the highest dividends. They make good sense for investors now.
Published:
Last Updated: